Search hospitals > Virginia > Falls Church
Inova Fairfax Hospital
Claim this profileFalls Church, Virginia 22042
Global Leader in Leukemia
Global Leader in Cancer
Conducts research for Lymphoblastic Leukemia-Lymphoma
Conducts research for Tumors
Conducts research for Lymphoid Leukemia
421 reported clinical trials
35 medical researchers
Summary
Inova Fairfax Hospital is a medical facility located in Falls Church, Virginia. This center is recognized for care of Leukemia, Cancer, Lymphoblastic Leukemia-Lymphoma, Tumors, Lymphoid Leukemia and other specialties. Inova Fairfax Hospital is involved with conducting 421 clinical trials across 564 conditions. There are 35 research doctors associated with this hospital, such as Robin Y. Dulman, David P. Lee, MD, Janakiraman Subramanian, and Adam Cohen, MD.Area of expertise
1Leukemia
Global LeaderPhiladelphia chromosome positive
Stage II
CD5 positive
2Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Robin Y. DulmanInova Fairfax Hospital4 years of reported clinical research
Studies Leukemia
Studies Lymphoma
25 reported clinical trials
64 drugs studied
David P. Lee, MDStanford Hospital and Clinics6 years of reported clinical research
Studies High Blood Pressure
Studies Vascular Disease
10 reported clinical trials
15 drugs studied
Janakiraman SubramanianSaint Luke's Hospital of Kansas City5 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
10 reported clinical trials
20 drugs studied
Adam Cohen, MDInova Schar Cancer Institute1 year of reported clinical research
Studies Glioblastoma
Studies Brain Tumor
10 reported clinical trials
21 drugs studied
Clinical Trials running at Inova Fairfax Hospital
Breast Cancer
Non-Small Cell Lung Cancer
Cancer
Gallbladder Cancer
Lung Cancer
Pancreatic Cancer
Rhabdomyosarcoma
Squamous Cell Carcinoma
Oropharyngeal Carcinoma
Laryngeal Cancer
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Giredestrant + Everolimus
for Advanced or Metastatic Breast Cancer
This Phase III, randomized, open-label, multicenter study will evaluate the efficacy and safety of giredestrant plus everolimus compared with the physician's choice of endocrine therapy plus everolimus in participants with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative locally advanced or metastatic breast cancer who have had previous treatment with cyclin-dependent kinase 4/6 inhibitors (CDK4/6is) and endocrine therapy, either in the locally advanced/metastatic or the adjuvant setting.
Recruiting2 awards Phase 37 criteria
Targeted Therapy
for Solid Tumors
This ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment directed by genetic testing. Patients with solid tumors that have spread to nearby tissue or lymph nodes (locally advanced) or have spread to other places in the body (advanced) and have progressed on at least one line of standard systemic therapy or have no standard treatment that has been shown to prolong overall survival may be candidates for these trials. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with some genetic changes or abnormalities (mutations) may benefit from treatment that targets that particular genetic mutation. ComboMATCH is designed to match patients to a treatment that may work to control their tumor and may help doctors plan better treatment for patients with locally advanced or advanced solid tumors.
Recruiting1 award Phase 217 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Inova Fairfax Hospital?
Inova Fairfax Hospital is a medical facility located in Falls Church, Virginia. This center is recognized for care of Leukemia, Cancer, Lymphoblastic Leukemia-Lymphoma, Tumors, Lymphoid Leukemia and other specialties. Inova Fairfax Hospital is involved with conducting 421 clinical trials across 564 conditions. There are 35 research doctors associated with this hospital, such as Robin Y. Dulman, David P. Lee, MD, Janakiraman Subramanian, and Adam Cohen, MD.
Where is Inova Fairfax Hospital located?
**Inova Fairfax Hospital**
- **Address:** 3300 Gallows Road, Falls Church, VA 22042-3300.
- **Directions:** From I-66 West, take exit 69A for Gallows Road South. Turn left onto Gallows Road; the hospital is located on your right after approximately 1 mile.
Who should I call to ask about financial aid or insurance network?
**Inova Fairfax Hospital Financial and Insurance Information:**
- **Financial Assistance:** For inquiries, please call the Financial Assistance Team at 571-472-5880. Available Monday to Friday, 8:00 a.m. to 4:30 p.m.
- **Insurance Inquiries:** For free health insurance enrollment assistance, contact Partnership For Healthier Communities at 703-698-2550 or email PHC@inova.org to schedule an appointment.
- **Billing Questions:** Please reach out to the Patient Accounts department at 571-423-5750 for any billing-related queries.
What insurance does Inova Fairfax Hospital accept?
Inova Fairfax Hospital accepts a wide range of insurance plans, including but not limited to Aetna, Anthem BlueCross BlueShield, Cigna, Kaiser Permanente, Humana, and United Healthcare, covering various plan types such as HMO, PPO, POS, EPO, Medicare Advantage, and Worker's compensation. The comprehensive list of accepted insurance plans as of June 25, 2020, encompasses specific plans like Aetna Better Health of Virginia, Anthem Healthkeepers Plus, BCBS Federal Employee Program, Cigna Connect, and many others, including plans for veterans and Medicaid Managed Care for the State of VA. It is crucial to verify coverage with your insurance carrier due to the possibility of plan changes.
What awards or recognition has Inova Fairfax Hospital received?
Inova Fairfax Hospital, located in Falls Church, Virginia, is celebrated for its Orthopedic Research Team's achievements in severe extremity trauma, earning the prestigious 2023 Kappa Delta Elizabeth Winston Lanier award. This hospital is a key component of the Inova Health System, renowned for its dedication to healthcare excellence and advancing community health equity.